The world’s first vaccine for mosquito-borne chikungunya virus has been approved by the UK’s Medicines and Healthcare ...

Sri Lanka is experiencing a rise in Chikungunya cases, with the highest number of infections being reported across the ...

The most common symptoms of chikungunya viral infection are fever and joint pain, often in the hands and feet. Other symptoms include muscle pain, headache, joint swelling, nausea, fatigue, and rash.

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Valneva’s single-dose chikungunya vaccine for use ...

Valneva's Ixchiq vaccine – which was cleared in the EU, the US, and Canada last year – is currently indicated for preventing ...

BHOPAL, Dec. 25 -- Madhya Pradesh is grappling with a rising number of Chikungunya cases, with the disease spreading rapidly despite crores of rupees spent annually to combat virus-borne illnesses.

At least five suspected cases of chikungunya were recorded in Davao City in January 2025. The residents who were suspected of ...

First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old.The virus-like particle (VLP) single-dose chikungunya ...

The UK approval marks the fourth regulatory approval Valneva has received for its single-shot chikungunya vaccine. The vaccine is currently approved in the United States (U.S.) 2, Europe 3 and Canada ...

UK MHRA grants marketing authorization to Valneva’s chikungunya vaccine, Ixchiq: Saint Herblain, France Thursday, February 6, 2025, 12:00 Hrs [IST] Valneva SE, a specialty vacci ...